Table 2 |
|||||
|
Malaria treatment prescribed for patients with clinically diagnosed malaria at day 0 (n = 294; treatment regime not known for 18 individuals). SP = sulfadoxine pyrimethamine. |
|||||
| Treatment Regime |
Total |
Adult |
Child |
||
| Microscopy positive |
Microscopy negative |
Microscopy positive |
Microscopy negative |
||
|
|
|||||
| No antimalarial |
112 |
17 (21.8%) |
7 (25%) |
43 (32.3%) |
35 (63.6%) |
| Antimalarial |
192 |
61 (78.2%) |
21 (75%) |
90 (67.7%) |
20 (36.4%) |
| Amodiaquine/SP |
133 |
44 |
20 |
57 |
12 |
| Chloroquine |
12 |
10 |
0 |
3 |
1 |
| Quinine |
1 |
1 |
0 |
0 |
0 |
| Amodiaquine alone |
7 |
0 |
0 |
6 |
1 |
| SP alone |
37 |
6 |
1 |
24 |
6 |
|
|
|||||
| Total |
294 |
78 |
28 |
133 |
55 |
|
|
|||||
|
Hume et al. Malaria Journal 2008 7:33 doi:10.1186/1475-2875-7-33 |
|||||
